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onset between January 2011 and December 2011. Variables included in the iScore are captured in the MOSAIC database. History of cancer and renal dialysis were collected by chart review if undetermined in the database. Although baseline stroke severity was assessed by the National Institutes of Health Stroke Scale in the MOSAIC database, the iScore allows the application of either the National Institutes of Health Stroke Scale or the Canadian Neurological Scale. Poor functional outcome, the primary outcome measure, was defined as a modified Rankin Scale 3 to 6 at 3 months after stroke onset. Secondary outcome was death at 3 months.
Statistical Analysis
We assessed performance of iScore using the C-statistic for discrimination and the Hosmer-Lemeshow test for calibration. Further details are provided in the online-only Data Supplement.
Results
Overall, there were 4061 patients eligible for the study (Figure in the online-only Data Supplement). Korean patients were younger and had milder stroke than participating patients in the derivation cohort from the Canadian Stroke Registry (Table) .
Poor functional outcome (modified Rankin Scale, 3-6) was found in 1496 patients (36.8%), whereas death at 3 months occurred in 294 patients (7.2%). There was a graded increase of poor functional outcome or death by quartiles of the iScore ( Figure 1 ). Poor functional outcome was 11.7% for quartile 1; 19.4% for quartile 2; 36.3% for quartile 3; and 79.7% for quartile 4.
The application of the iScore to the Korean cohort revealed a good discrimination: the C-statistics for poor functional outcome 0.819 (95% confidence interval, 0.805-0.833) and 0.861 (95% confidence interval, 0.840-0.883) for death at 3 months (see receiver operating characteristic curve in the online-only Data Supplement). The calibration was also good for primary (Hosmer-Lemeshow test, P=0.624) and secondary outcomes (Hosmer-Lemeshow test, P=0.757). There was a high correlation between observed and expected outcomes predicted by the iScore for both poor functional status (Pearson correlation coefficient, r=0.990; Figure 2 ) and death at 3 months (r=0.969; Figure in the online-only Data Supplement).
Discussion
There are substantial differences in clinical presentation, risk factors, and stroke mechanisms between Asian and white patients with stroke, 6 thus affecting stroke outcomes. Our results showed that the iScore provided accurate estimations for poor functional outcome (modified Rankin Scale, [3] [4] [5] [6] or death at 3 months in Korean patients with an acute ischemic stroke. Despite differences in baseline characteristics of the Korean cohort (compared with the validation cohort from Canada), the C-statistics of the iScore for the primary and secondary outcomes were >0.81.
Together, these findings have practical clinical implications. First, limited information is available on the performance of risk scores when applied to ethnically different populations/ groups other than white. A prediction model developed from the Get With the Guidelines-Stroke has been validated to predict in-hospital mortality in Chinese patients with stroke. 9 Although in-hospital mortality is also a valuable prognostic measure, clinical outcomes at 3 months after stroke as measured in our study are more widely used in randomized trials and routine clinical practice. Second, although the iScore was developed to predict 30-day mortality, our study showed 
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May 2013 a good performance in prediction of outcomes at 3 months without any modification of the original elements. The current study has a limitation. It is possible that variables not included in the iScore, known to influence stroke outcomes (eg, imaging findings), may improve discrimination power of the iScore.
In conclusion, our results show that the iScore can be reliably applied to Asian patients with an ischemic stroke to estimate clinical outcomes at 3 months. Other prognostic scores may be useful in estimating stroke outcomes, but remain to be validated in other ethnic groups having different risk factors, mechanisms, and stroke subtypes. 
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Statistical analysis
Continuous variables were compared by using Student t-test or Wilcoxon rank-sum test.
Categorical variables were compared by using chi-square test.
The National Institutes of Health Stroke Scale (NIHSS) score of Korean patients was converted to the CNS by following formula as reported in the previous study 1 : a CNS of 1-4
= an NIHSS score of 14-22 (severe), a CNS of 5-7 = an NIHSS score of 9-13 (moderate), a CNS of ≤8 = an NIHSS score of ≤8 (mild), and a CNS of 0 = an NIHSS score of >22.
Details of the analytic approach for the creation of the iScore have been published elsewhere. 2 We used quartiles of risk score to divide the validation cohort into 4 risk categories and compared distribution of modified Rankin Scale between them. Performance of iScore was assessed using C-statistic for discrimination, and the Hosmer-Lemeshow (HL) test for calibration. We also assessed the calibration by using plot of observed versus 
